Re:Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum.
Guffroy
M
M
Hodge
T
T
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001284:Atrophy / Q000139:chemically induced; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D002432:Cecum / Q000187:drug effects* / Q000473:pathology; D002945:Cisplatin / Q000009:adverse effects; D003967:Diarrhea / Q000139:chemically induced*; D007082:Ileum / Q000187:drug effects* / Q000473:pathology; D007413:Intestinal Mucosa / Q000187:drug effects*; D000077146:Irinotecan; D051379:Mice
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin